List of companies in Marshall Wace's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
MetaMask is a crypto wallet and gateway to blockchain apps in the Ethereum ecosystem. MetaMask is a crypto wallet that allows users to manage their digital assets through a browser extension or mobile app. | ||||||
Exscientia is an Oxford-based biotechnology company using artificial intelligence to automate drug discovery. | ||||||
Circle is a peer-to-peer payments technology company that is headquartered in Boston, Massachusetts and was founded in 2013 by Jeremy Allaire and Sean Neville. | ||||||
ConsenSys is a blockchain development studio building decentralized applications utilizing the Ethereum platform. It was founded by Joseph Lubin in 2014. | ||||||
Varo is a San Francisco-based mobile banking business allowing customers to pay their bills, cover their expenses and build their wealth. | ||||||
A blockchain and cryptocurrency development company developing blockchain based business solutions for investment funds, administrators, trading firms, exchanges and accounting firms. | ||||||
Tipalti automates the way companies pay suppliers, partners, publishers and employees with cloud-based solutions which addresses all phases of the payables workflow. | ||||||
Turtlemint is a Mumbai-based insurance technology company providing a platform to facilitate the process of buying and managing insurance policies. | ||||||
A company providing financing and transaction technology for merchants. | ||||||
Amylyx Pharmaceutical is a combination of existing products founded in 2013 by Justin Klee. | ||||||
Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience. | ||||||
Parse Biosciences provides researchers with the ability to perform single cell sequencing | ||||||
Neurogastrx is a functional and motility gastrointestinal disorders founded in 2012. | ||||||
Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms. | ||||||
Accelerant provides insurance capacity, a technology platform and investment for MGAs in property and casualty insurance. | ||||||
Inquis Medical is developing thrombectomy technology, enabling an efficient single-pass thrombectomy with minimal blood loss. | ||||||
Pathalys Pharma is a biopharmaceutical company developing treatments for chronic kidney disease, with a focus on managing hyperphosphatemia in patients. | ||||||
